4.4 (0.83%)
4.4 (0.83%) 5.48 pm | 10 May 2012 | Source: CNBC-TV18
Higher tax expenses led to a decline in consolidated net profit of pharma company, Lupin in the fourth quarter of FY12. The company posted a decline o...
3.46 pm | 10 May 2012 | Source: Moneycontrol.com
Pharma company Lupin's fourth quarter consolidated net profit declined 31% year-on-year to Rs 156 crore due to higher tax expenses....
9.39 am | 10 May 2012 | Source: CNBC-TV18
Pharmaceutical company Lupin is expected to report a growth of 17.9% year-on-year and 14% quarter-on-quarter in its profit after tax of Rs 267 crore f...
3.14 pm | 25 Jan 2012 | Source: Moneycontrol.com
Lupin has reported a sales turnover of Rs 1,405.38 crore and a net profit of Rs 214.61 crore for the quarter ended Dec '11...
3.38 pm | 24 Jan 2012 | Source: CNBC-TV18
In an interview to CNBC-TV18, Dr Kamal K Sharma, managing director, Lupin said, the company will be able to maintain its performance during the year. ...
2.56 pm | 24 Jan 2012 | Source: Moneycontrol.com
Pharma company Lupin's consolidated net profit for the third quarter rose 5% year-on-year at Rs 235.1 crore as strong sales growth was offset by highe...
10.00 am | 24 Jan 2012 | Source: CNBC-TV18
Lupin is expected to report a profit after tax of Rs 233 crore in the quarter ended December FY12, a moderate growth of 4% as compared to Rs 224 crore...
10.32 pm | 02 Dec 2011 | Source: CNBC-TV18
After a sluggish first quarter, pharma universe reported some encouraging numbers in the second quarter. This is with some support from stable growth ...